A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
=========================================================================================================================================

* Aung Naing
* Justin F Gainor
* Hans Gelderblom
* Patrick M Forde
* Marcus O Butler
* Chia-Chi Lin
* Sunil Sharma
* Maria Ochoa de Olza
* Andrea Varga
* Matthew Taylor
* Jan H M Schellens
* Hongqian Wu
* Haiying Sun
* Antonio P Silva
* Jason Faris
* Jennifer Mataraza
* Scott Cameron
* Todd M Bauer